RNFL Thickness Mapping Aids Detection, Surveillance Of Glaucoma Progression

Tuesday, October 2, 2012

Ocular Surgery News

Analysis of retinal nerve fiber layer thickness maps created with optical coherence tomography enabled the detection of topographic changes associated with glaucoma progression, a study found.

Full Story

All of the following drugs are FDA approved for the treatment of minimally classic subfoveal CNV in patients with neovascular AMD with evidence of recent disease progression (loss of vision, growth of CNV on FA, new macular hemorrhage) except for which one?
1. Pegaptanib sodium (Macugen)
2. Verteporfin (Visudyne PDT)
3. Ranibizumab (Lucentis)
4. None of the above
5. All of the above
Check The Answer

CareCloud Central
CareCloud Central is a medical practice ... view product
SPECTRALIS Diagnostic Imaging Platform
A modular and upgradeable ophthalmic ... view product

View all Featured Products »

Keep up with our latest articles, news and events. Plus, get special offers and more delivered to your inbox.

Like us
on Facebook Follow us
on Twitter

OphthalmologyWeb wants to hear from you. Submit your case studies, clinical pearls, practice management tips, editorial, or other manuscripts.

Learn more about writing for us

AdGlare Leaderboard

RNFL Thickness Mapping Aids Detection, Surveillance Of Glaucoma Progression

Comments

Quick Quiz

All of the following drugs are FDA approved for the treatment of minimally classic subfoveal CNV in patients with neovascular AMD with evidence of recent disease progression (loss of vision, growth of CNV on FA, new macular hemorrhage) except for which one?

AdGlare RMR Ad

Featured Products

CareCloud Central

SPECTRALIS Diagnostic Imaging Platform

Follow OphthalmologyWeb

Write for Us

AdGlare RMR2